Human APRIL / TNFSF13 Protein, His,Flag Tag, active trimer (MALS verified)
分子別名（Synonym）
APRIL,TNFSF13,TALL-2,TRDL-1,CD256,TALL2,ZTNF2
表達(dá)區(qū)間及表達(dá)系統(tǒng)（Source）
Human APRIL Protein, His,Flag Tag (APL-H52D1) is expressed from human 293 cells (HEK293). It contains AA Gln 111 - Leu 250 (Accession # O75888-1) trimer Design.
Predicted N-terminus: His
蛋白結(jié)構(gòu)（Molecular Characterization）
This protein carries a polyhistidine tag at the N-terminus, followed by a flag tag.
The protein has a calculated MW of 50.2 kDa. The protein migrates as 50-55 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under non-reducing (NR) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素（Endotoxin）
Less than 1.0 EU per μg by the LAL method.
純度（Purity）
>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
制劑（Formulation）
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法（Reconstitution）
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲（Storage）
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景（Background）
APRIL（增殖誘導(dǎo)配體）也稱為腫瘤壞死因子配體超家族成員13，TALL-2，TRDL-1，CD256，TNFFSF 13，與TNFRSF13B/TACI和TNFRSF17/BCMA結(jié)合的細(xì)胞因子。APRIL是主要與血液系統(tǒng)惡性腫瘤相關(guān)的腫瘤壞死因子家族的細(xì)胞因子。密切相關(guān)的TNF家族配體B細(xì)胞活化因子（BAFF）和增殖誘導(dǎo)配體（APRIL）用于成熟B淋巴細(xì)胞的產(chǎn)生和維持。BAFF和APRIL都組裝成同源三聚體，結(jié)合并激活它們部分共享的幾種受體。此外，APRIL的表達(dá)受miR-145在GC細(xì)胞中的調(diào)節(jié)。
關(guān)鍵字： APRIL;APRIL蛋白;APRIL重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group（股票代碼：301080）是成立于2010年的跨國生物科技公司，是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球，橫跨亞洲、北美洲、歐洲，在中國、美國、瑞士等12個城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計服務(wù)客戶超6000家，與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。